Feature

Eledon leading a paradigm shift in immunosuppression therapy in organ transplantation

Eledon Pharmaceuticals (NASDAQ: ELDN) is pioneering a potential breakthrough in immunosuppression therapy aimed at extending the longevity of transplanted organs and enhancing the overall health and quality of life for...

May 27, 2025

Feature

Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions

Closely held Longhorn Vaccines and Diagnostics is developing peptide vaccines and monoclonal antibodies aimed at preventing and reducing the global burden of medical conditions caused by key bacterial toxins, including...

May 20, 2025

Feature

Terns shaping the future of human health with potential best-in-class therapies for serious diseases

Terns Pharmaceuticals (NASDAQ:TERN) is developing a portfolio of novel, oral small-molecule product candidates based on clinically validated mechanisms of action to address serious diseases including oncology and...

May 6, 2025

Feature

Tasman redefining treatment for hard-to-treat depression with breakthrough oral ketamine monotherapy

Closely held Tasman Therapeutics is shifting the treatment landscape for treatment-resistant depression (TRD) with its registered, proprietary formulation—a first-of-its-kind, oral extended-release ketamine tablet.

April 29, 2025

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Eledon leading a paradigm shift in immunosuppression therapy in organ transplantation

Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions

Terns shaping the future of human health with potential best-in-class therapies for serious diseases

Tasman redefining treatment for hard-to-treat depression with breakthrough oral ketamine monotherapy

NEWS

Genflow and CER agree to long-term R&D collaboration

enGene appoints Amy Pott as chief global commercialization officer

NeoGenomics introduces PanTracer genomic profiling tests at ASCO 2025

CellCentric appoints Celia Economides as CFO & CBO

Accomplished medtech industry veteran, Laurie Vertuccio, joins Profound Medical as VP of Global Marketing

Perimeter partners with Intermountain Health to study benefits of using OCT and AI to reduce cancer reoperations

Scienture announces executive leadership transition

FDA clears Quoin’s second QRX003 NS pivotal study

NorthStrive completes Phase 1 review for oral myostatin-engineered probiotic

Just a few of the companies we’ve highlighted along the way

Subscribe